面部皮肤型孢子丝菌病72例临床分析  

Clinical Analysis of 72 Cases of Facial Cutaneous Sporotrichosis

作　　者：李鹤玉[1] 刘慧瑜[1] 盛宇[1] 冯广忠[2] 王晓慧[1] 

机构地区：[1]哈尔滨医科大学附属第一医院皮肤性病科,150001 [2]哈尔滨医科大学附属第一医院眼科,150001

出　　处：《中华皮肤科杂志》2004年第8期449-451,共3页Chinese Journal of Dermatology

摘　　要：目的报道面部皮肤型孢子丝菌病72例.方法详细观察72例患者的皮损表现,逐一做真菌学检查,部分做病理检查.采用碘化钾、伊曲康唑、特比萘芬等联合疗法治疗.结果颜面孢子丝菌病的皮损形态复杂,其中淋巴管型占9.72%,局限型占90.28%,有明确外伤史的26.4%.以碘化钾为基础的联合治疗,6～8周全部治愈.结论皮损表现和真菌学检查是诊断孢子丝菌病的重要依据.颜面孢子丝菌病形态分布以局限型为主.基层误诊率高达16%.碘化钾为首选基础用药.Objective To report the result of analysis of 72 cases of facial cutaneous sporotrichosis. Methods Seventy-two patients were included in this study. They were diagnosed as facial cutaneous sporotrichosis according to clinical mainfestations and fungal culture. Histopathological examinations were done in some atypical cases. The patients were treated with combined antifungal agents. Results The lesion forms were varied, in which lymphangitic cutaneous form accounted for 9.72% and fixed cutaneous form accounted for 90.28% respectively. Nineteen cases (26.4%) had a history of skin trauma before the cutaneous lesions. All of the patients were successfully treated with potassium iodide and/or itraconazole, terbinafine for 6-8 weeks. Conclusions The skin lesions and mycological examination are the important evidences for the diagnosis of sporotrichosis. The main form of the facial cutaneous sporotrichosis is the fixed cutaneous form. The misdiagnosis rate is 16% in primary level clinics. Potassium iodide is an effective and inexpensive medicine in the treatment of cutaneous sporotrichosis.

关 键 词：面部皮肤型孢子丝菌病 碘化钾 伊曲康 特比萘芬 治疗 

分 类 号：R756[医药卫生—皮肤病学与性病学]